Production (Stage)
BioRestorative Therapies, Inc.
BRTX
$1.66
$0.063.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.10M | -8.98M | -9.65M | -3.79M | -5.47M |
| Total Depreciation and Amortization | 198.20K | 189.10K | 181.40K | 175.20K | 169.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.73M | 531.30K | 1.93M | -3.37M | -1.19M |
| Change in Net Operating Assets | 473.20K | 28.70K | 69.20K | 27.60K | 117.60K |
| Cash from Operations | -8.69M | -8.23M | -7.47M | -6.95M | -6.37M |
| Capital Expenditure | -142.60K | -106.20K | -163.80K | -117.20K | -110.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 7.95M | 620.70K | -939.10K | -1.94M | -4.10M |
| Cash from Investing | 7.81M | 514.60K | -1.10M | -2.06M | -4.22M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.60K | -- | -- | -- | -- |
| Issuance of Common Stock | 1.68M | 8.12M | 8.21M | 9.47M | 9.88M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -692.10K | -744.00K | -617.70K | -22.30K | -9.50K |
| Cash from Financing | 953.60K | 7.38M | 7.59M | 9.44M | 9.87M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 71.70K | -336.50K | -984.60K | 431.40K | -716.60K |